Coronavirus Outbreak: Trials for pre-existing drugs begin as potential treatments for COVID-19

Trials are being done using arthritis, HIV and a combination of other existing drugs to treat the novel coronavirus.

Reuters March 17, 2020 13:44:02 IST
Coronavirus Outbreak: Trials for pre-existing drugs begin as potential treatments for COVID-19

Drugs used for treating arthritis are being tested as treatments for COVID-19 , the disease caused by a new coronavirus , as researchers rush to find ways of helping patients and slowing the number of infections.

Sanofi and Regeneron Pharmaceuticals said on Monday they began a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment, while in Spain a separate trial is studying if a combination of two drugs can slow down the spread of coronavirus among people.

Enrolments for the mid-to-late stage trial of Kevzara, an immune-system modifying drug known as a monoclonal antibody, will begin immediately and test up to 400 patients, Sanofi and Regeneron said in a joint statement.

 <span class=Coronavirus Outbreak Trials for preexisting drugs begin as potential treatments for COVID19" width="1280" height="720" />

Barcelona-based researchers said they would administer a drug used to treat HIV to a coronavirus -infected person.

Regeneron in February announced a partnership with the U.S. Department of Health and Human Services to develop a treatment for the new coronavirus , called SARS-CoV2, and said it would focus on monoclonal antibodies.

The virus that emerged in central China in December has now infected more than 179,000 people worldwide, according to the Johns Hopkins University, which is tracking these figures.

Doctors have seen that many of those who become critically ill from SARS-CoV2 are experiencing a so-called cytokine storm, which happens when the immune system overreacts and attacks the body’s organs. Some researchers think drugs that can suppress the immune system, including monoclonal antibodies, might be useful for limiting this autoimmune response.

Meanwhile, Barcelona-based researchers said on Monday they would administer a drug used to treat HIV - containing darunavir and cobicistat - to a coronavirus -infected person.

The patient’s close contacts would be administered hydroxychloroquine, a drug for malaria and rheumatoid conditions because laboratory experiments suggest it prevents this strain of coronavirus from reproducing.

“The goal of our study is to separate the transmission chains,” Oriol Mitja, a researcher at Germans Trias I Pujol Research Institute, told a news briefing.

Patients with coronavirus can infect between 5% and 15% of the people they come into contact with during the 14 days after starting to show symptoms, he said.

The trial’s goal is to reduce that number below 14 days and also to reduce the percentage of contacts infected and researchers plan to analyze the results in 21 days.

Around 200 patients with coronavirus and 3,000 of their close contacts will take part in the trial, which has private and public funding.

Mitja - who plans to talk with World Health Organization officials this week - said there were two other similar projects in Australia and the United States, but that his is in the lead.

Also on Monday, Madrid’s La Paz-Carlos III hospital announced a trial to administer another antiviral drug, Remdesivir, to voluntary patients with serious and milder cases of coronavirus , Madrid’s regional government said in a statement.

About 1,000 patients will take part in the European-wide trial, it said.

Updated Date:

also read

COVID-19: Pause sale of captured wild animals in wet markets as emergency measure, WHO urges nations
World

COVID-19: Pause sale of captured wild animals in wet markets as emergency measure, WHO urges nations

The coronavirus' origins have been the source of intense speculation, much of it centred around the likelihood that it was carried by bats and passed to humans through an intermediary species

'Kill the Bill' protests: 107 arrested as demonstrators clash with police at central London rally
World

'Kill the Bill' protests: 107 arrested as demonstrators clash with police at central London rally

The Police and Crime Bill proposes to give police in England and Wales more power to impose conditions on non-violent protests including those which are deemed too noisy or a nuisance

A haunting silence pervades cafes, restaurants in Greece as the country's second lockdown continues for six months
long reads

A haunting silence pervades cafes, restaurants in Greece as the country's second lockdown continues for six months

Restaurants, bars and cafes, whose nature it is to gather groups of people closely together, have remained shut since November when the Greek government imposed a second lockdown to curb the spread of COVID-19 infections